Catherine Pearce, DHSc, MBA

Dr. Pearce serves as the CEO of JucaBio, LLC, where she continues to champion her unique model of revitalizing dormant assets, fostering a new wave of biotech ventures.  Currently, she is leading 2 JucaBio portfolio companies, AllRock and AllPrime. AllRock raised a Series A in 2024 to establish the benefits of a first-in-class therapeutic for pulmonary hypertension and interstitial lung diseases.

In 1997, Dr. Pearce began her career at Hoffman-LaRoche, followed by significant roles at Merck, where she spearheaded the launch of innovative therapeutics in cardiovascular medicine. Her tenure at Medpace, Inc. from 2001 saw her ascend as a Clinical Project Manager overseeing numerous global Phase 1-4 studies across diverse therapeutic domains, including neurology, diabetes, and kidney diseases.

In 2007, Dr. Pearce embarked on establishing Medpace's inaugural business development and marketing teams, a pivotal initiative that underscored her strategic vision. Transitioning to Teva in 2013 as VP of R&D, she led a pioneering division focused on repurposing generics. Dr. Pearce's entrepreneurial spirit led her to co-found CinRx in 2015, a biotech incubator dedicated to revitalizing early-stage assets from pharmaceuticals, biotechs, and academia. Under her leadership, CinRx flourished, nurturing six innovative portfolio companies spanning oncology, obesity, and hypertension.

Notably, as COO and co-founder of CinCor, Dr. Pearce orchestrated the company's growth trajectory, culminating in a successful IPO in 2022. Her stewardship was instrumental in the acquisition of CinCor by AstraZeneca in 2023, a landmark transaction valued at up to $1.8 billion.

Beyond her executive roles, she serves on several private biotech boards, advises numerous startups, and holds a distinguished position as a Board of Trustee Member at Xavier University, where she earned both her undergraduate degree and MBA. Dr. Pearce earned her Doctorate in Health Sciences from Nova Southeastern University, underscoring her commitment to advancing healthcare innovation through strategic leadership and entrepreneurial acumen.